XpressBioX: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
XpressBioX
Largest movements
- Receivables within one year +€111,492
up €111,492 (+3294.7%), from €3,384 to €114,876
of which Other amounts receivable: +€114,676
- Formation expenses -€106,949
down €106,949 (-66.6%), from €160,599 to €53,650
No liability line moved by more than 1% of the balance sheet total.
- Financial charges -€324,485
down €324,485 (-98.9%), from €328,118 to €3,633
- Financial income -€205,195
down €205,195 (-99.8%), from €205,630 to €435
- Services and other goods -€5,958
down €5,958 (-32.3%), from €18,428 to €12,470
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €8,913,983 | €8,918,526 | +€4,543 | +0.1% |
| Formation expenses | 20 | €160,599 | €53,650 | -€106,949 | -66.6% |
| Fixed assets | 21/28 | €8,750,000 | €8,750,000 | = | 0.0% |
| Financial fixed assets | 28 | €8,750,000 | €8,750,000 | = | 0.0% |
| Affiliated companies | 280/1 | €8,750,000 | €8,750,000 | = | 0.0% |
| Participating interests | 280 | €8,750,000 | €8,750,000 | = | 0.0% |
| Amounts receivable | 281 | €0 | €0 | = | |
| Current assets | 29/58 | €3,384 | €114,876 | +€111,492 | +3294.7% |
| Amounts receivable within one year | 40/41 | €3,384 | €114,876 | +€111,492 | +3294.7% |
| Trade receivables | 40 | €3,384 | €200 | -€3,184 | -94.1% |
| Other amounts receivable | 41 | - | €114,676 | +€114,676 | |
| Cash at bank and in hand | 54/58 | €0 | €0 | = | |
| Total equity and liabilities | 10/49 | €8,913,983 | €8,918,526 | +€4,543 | +0.1% |
| Equity | 10/15 | €8,828,981 | €8,903,602 | +€74,621 | +0.8% |
| Contributions | 10/11 | €9,207,800 | €9,207,800 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€378,819 | -€304,198 | +€74,621 | +19.7% |
| Amounts payable | 17/49 | €85,002 | €14,924 | -€70,078 | -82.4% |
| Amounts payable within one year | 42/48 | €85,002 | €14,924 | -€70,078 | -82.4% |
| Trade debts | 44 | €7,669 | €5,023 | -€2,646 | -34.5% |
| Suppliers | 440/4 | €7,669 | €5,023 | -€2,646 | -34.5% |
| Taxes, remuneration and social security | 45 | €9,740 | €9,901 | +€161 | +1.7% |
| Taxes | 450/3 | €9,740 | €9,901 | +€161 | +1.7% |
| Other amounts payable | 47/48 | €67,593 | - | -€67,593 | |
| Operating income | 70/76A | €198,000 | €198,237 | +€237 | +0.1% |
| Turnover | 70 | €198,000 | €198,000 | = | 0.0% |
| Other operating income | 74 | - | €237 | +€237 | |
| Operating charges | 60/66A | €126,345 | €120,418 | -€5,927 | -4.7% |
| Services and other goods | 61 | €18,428 | €12,470 | -€5,958 | -32.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €106,950 | €106,949 | -€1 | 0.0% |
| Other operating charges | 640/8 | €967 | €999 | +€32 | +3.3% |
| Operating profit (loss) | 9901 | €71,655 | €77,819 | +€6,164 | +8.6% |
| Financial income | 75/76B | €205,630 | €435 | -€205,195 | -99.8% |
| Recurring financial income | 75 | €205,630 | €435 | -€205,195 | -99.8% |
| Income from financial fixed assets | 750 | €198,190 | - | -€198,190 | |
| Income from current assets | 751 | €7,440 | €435 | -€7,005 | -94.2% |
| Financial charges | 65/66B | €328,118 | €3,633 | -€324,485 | -98.9% |
| Recurring financial charges | 65 | €328,118 | €3,633 | -€324,485 | -98.9% |
| Debt charges | 650 | €326,127 | €535 | -€325,592 | -99.8% |
| Other financial charges | 652/9 | €1,991 | €3,098 | +€1,107 | +55.6% |
| Profit (loss) for the period before taxes | 9903 | -€50,833 | €74,621 | +€125,454 | |
| Profit (loss) for the period | 9904 | -€50,833 | €74,621 | +€125,454 | |
| Profit (loss) for the period to be appropriated | 9905 | -€50,833 | €74,621 | +€125,454 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.